Kee Song Bio-Technology Holdings (ROCO:1258) LT-Debt-to-Total-Asset : 0.38 (As of Mar. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Kee Song Bio-Technology Holdings LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Kee Song Bio-Technology Holdings's long-term debt to total assests ratio for the quarter that ended in Mar. 2023 was 0.38.

Kee Song Bio-Technology Holdings's long-term debt to total assets ratio declined from Mar. 2022 (0.43) to Mar. 2023 (0.38). It may suggest that Kee Song Bio-Technology Holdings is progressively becoming less dependent on debt to grow their business.

Kee Song Bio-Technology Holdings LT-Debt-to-Total-Asset Historical Data

The historical data trend for Kee Song Bio-Technology Holdings's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kee Song Bio-Technology Holdings LT-Debt-to-Total-Asset Chart

Kee Song Bio-Technology Holdings Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.44

0.46

0.36

0.43

0.39

Kee Song Bio-Technology Holdings Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.43	0.42	0.43	0.39	0.38

Kee Song Bio-Technology Holdings LT-Debt-to-Total-Asset Calculation

Kee Song Bio-Technology Holdings's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2022 is calculated as

LT Debt to Total Assets (A: Dec. 2022 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2022 )	/	Total Assets (A: Dec. 2022 )
	=	914.627	/	2341.95
	=	0.39

Kee Song Bio-Technology Holdings's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2023 is calculated as

LT Debt to Total Assets (Q: Mar. 2023 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2023 )	/	Total Assets (Q: Mar. 2023 )
	=	865.974	/	2266.869
	=	0.38

Kee Song Bio-Technology Holdings (ROCO:1258) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Kee Song Bio-Technology Holdings LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Kee Song Bio-Technology Holdings's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Kee Song Bio-Technology Holdings (ROCO:1258) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kee Song Bio-Technology Holdings Ltd (ROCO:1258) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

Songjiang Road, 104, 8th Floor, No. 51, Zhongshan District, Taipei, TWN, 104

Website

https://www.keesongbiotech.com

Kee Song Bio-Technology Holdings Ltd is engaged in the processing and distribution of meat products. This includes poultry, production, and sale of chicken as well as the trade of frozen meat and prepared food. It has two reportable segments; the Poultry and processing distribution segment which is engaged in the business of importing, slaughtering, wholesaling, and retailing poultry and consumable goods of all kinds; and the Poultry farming segment involved in the business of poultry farming. It derives a majority of its revenue from the poultry farming segment.

Kee Song Bio-Technology Holdings (ROCO:1258) Headlines

No Headlines